The Convergent Bioscience and Technology Institute (CBATI) at Indiana University Indianapolis is an interdisciplinary research hub focused on accelerating translational biomedical innovation. CBATI integrates bioscience, engineering, informatics, and clinical expertise to develop smart sensors and medical devices, wearable and implantable technologies, molecular diagnostics, advanced drug discovery and delivery, and AI‑enabled healthcare solutions. The institute emphasizes moving discoveries efficiently from bench to bedside through strong collaboration with clinicians, industry partners, and innovation programs supporting commercialization and real‑world impact.
1. Smart Wearable Sensor for Orthopedic Recovery (Industry Partner – Medical Device Company)
Business problem: The partner sought objective, continuous monitoring of patient recovery following orthopedic surgery to improve outcomes and reduce readmissions.
Scoping: We jointly defined clinical use cases, performance requirements, data types, and regulatory constraints, aligning engineering milestones with clinical validation needs.
Delivered: A wearable sensing prototype with embedded analytics, validation data from pilot studies, and a translational roadmap supporting regulatory and commercialization planning.
2. AI‑Enabled Molecular Diagnostic for Early Disease Detection (External Partner – Health Technology Startup)
Business problem: Current diagnostics lacked sensitivity and scalability for early disease detection in real‑world settings.
Scoping: We co‑developed the technical scope covering biomarker selection, assay integration, data pipelines, and model validation aligned with clinical deployment needs.
Delivered: A validated prototype integrating molecular assays with AI‑driven analysis, along with performance benchmarks and documentation for investor and regulatory review.